Mc Causland, Finnian R.
Pfeffer, Marc A.
Article History
First Online: 12 April 2018
Competing interests
: M.A.P. receives research support from Novartis and serves as a consultant for AstraZeneca, Bayer, Boehringer Ingelheim, DalCor, Genzyme, Gilead, GlaxoSmithKline, Janssen, Lilly, Novartis, Novo Nordisk, Relypsa, Sanofi, Teva and Thrasos. He also has stock options for DalCor. F.R.M. reports no competing interests.